Both in Pharmaceuticals
Nurix Therapeutics vs Stoke Therapeutics
Over the past year NRIX returned +30.1% and STOK returned +8.3%; their daily moves had a correlation of 0.27.
NRIX +30.1% STOK +8.3%Growth of $1, one year, split-adjusted
| Metric | NRIX | STOK |
|---|---|---|
| Price | $15.95 | $27.45 |
| Market cap | $1.74B | $1.77B |
| Today | −38.23% | +1.70% |
| 1 month | −29.4% | +12.6% |
| 6 months | −5.5% | −17.5% |
| Year to date | −15.9% | −13.5% |
| 1 year | +26.4% | +5.2% |
| Revenue growth (YoY) | +8426.3% | +5.9% |
| Gross margin | 100.0% | 100.0% |
| Net margin | 81.7% | −654.3% |
| P/E (TTM) | 5.9× | — |
| Price / sales | 2.5× | 62.8× |
| Net cash | $1.05B | $319.2M |
| Dividend yield | — | — |
| Volatility (60d) | 104.6% | 47.9% |
| Short % of float | 21.0% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).